Artemether-Lumefantrine Tablets
>- Artemether-lumefantrine tablets are a fixed-dose combination antimalarial medicament. Both active ingredients, artemether and lumefantrine, are explicitly listed in Subheading Note 2 to Chapter 30, and the product is put up in measured doses for retail sale. This qualifies it for classification under tariff item 3004.60.00 as a medicament containing antimalarial active principles.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the tablets contain additional active ingredients not listed in Subheading Note 2
Medicaments with other active principles fall under the residual medicament tariff item.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• >- Ensure the product is labelled with a Drug Identification Number (DIN) or Natural Product Number (NPN) from Health Canada before importation
• Declare the exact active ingredients and dosage form on the CBSA customs declaration to support classification under 3004.60.00
• Keep certificates of analysis and manufacturing records available in case of a CBSA verification request
Related Products under Tariff item 3004.60.00
Artesunate 50mg Injection Vials
>- Artesunate injection vials contain artesunate, an artemisinin derivative listed in Subheading Note 2, formulated as a lyophilized powder for reconstitution. The product is presented in single-dose vials for therapeutic use in severe malaria. This meets the criteria for tariff item 3004.60.00 as a medicament containing an antimalarial active principle.
Atovaquone-Proguanil Hydrochloride Tablets
Atovaquone-Proguanil Hydrochloride Tablets are a fixed-dose combination antimalarial medication, typically containing 250 mg of atovaquone and 100 mg of proguanil hydrochloride per tablet. They are used for the prophylaxis and treatment of malaria, particularly in regions with chloroquine-resistant strains. These tablets are classified under tariff item 3004.60.00 because they contain antimalarial active principles listed in Subheading Note 2 to Chapter 30 and are put up in measured doses for retail sale.
Chloroquine Phosphate Tablets 250mg
>- Chloroquine phosphate tablets contain chloroquine, an antimalarial active principle explicitly listed in Subheading Note 2. The tablets are put up in blister packs in measured doses for retail sale, making them eligible for classification under tariff item 3004.60.00. This product is used for both prophylaxis and treatment of malaria.
Doxycycline Hyclate 100mg Capsules
Doxycycline Hyclate 100mg Capsules are an antibiotic used as an antimalarial in combination therapy, particularly for multidrug-resistant strains of malaria. Each capsule contains 100 mg of doxycycline hyclate and is packaged in blister packs or bottles for retail sale. They are classified under tariff item 3004.60.00 because doxycycline is listed in Subheading Note 2 as an antimalarial active principle, and the product is in measured doses for therapeutic use.
Mefloquine Hydrochloride Tablets 250mg
>- Mefloquine hydrochloride tablets contain mefloquine, an antimalarial active principle listed in Subheading Note 2. The tablets are presented in blister packs in measured doses for retail sale, used for weekly malaria prophylaxis. This product is classifiable under tariff item 3004.60.00 as a medicament containing an antimalarial active principle.
Primaquine Phosphate Tablets 15mg
>- Primaquine phosphate tablets contain primaquine, an 8-aminoquinoline antimalarial active principle listed in Subheading Note 2. The tablets are put up in measured doses for retail sale, used for radical cure of Plasmodium vivax malaria. This product qualifies for tariff item 3004.60.00 as a medicament containing an antimalarial active principle.